Ind-Swift Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Ind-Swift Laboratories has a total shareholder equity of ₹7.3B and total debt of ₹8.0B, which brings its debt-to-equity ratio to 109.8%. Its total assets and total liabilities are ₹18.0B and ₹10.7B respectively. Ind-Swift Laboratories's EBIT is ₹2.0B making its interest coverage ratio 2.8. It has cash and short-term investments of ₹132.0M.
Key information
109.8%
Debt to equity ratio
₹8.02b
Debt
Interest coverage ratio | 2.8x |
Cash | ₹132.04m |
Equity | ₹7.30b |
Total liabilities | ₹10.69b |
Total assets | ₹17.99b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532305's short term assets (₹11.7B) exceed its short term liabilities (₹3.2B).
Long Term Liabilities: 532305's short term assets (₹11.7B) exceed its long term liabilities (₹7.5B).
Debt to Equity History and Analysis
Debt Level: 532305's net debt to equity ratio (108%) is considered high.
Reducing Debt: 532305's debt to equity ratio has reduced from 195.4% to 109.8% over the past 5 years.
Debt Coverage: 532305's debt is well covered by operating cash flow (26.9%).
Interest Coverage: 532305's interest payments on its debt are not well covered by EBIT (2.8x coverage).